Cannabis is one of the most studied plants of the decade. Treatment-resistant epilepsy, chronic pain, spasticity, anxiety, insomnia, effects on cancer or Parkinson's patients: scientific publications are multiplying, clinical trials are piling up, and regulators are moving forward cautiously.
Since 2015, Newsweed has been tracking all the news at the intersection of cannabis and health: study results, market launches (Sativex, Epidiolex), prescription debates, patient testimonials and scientific controversies. A rigorous, French-language watch for patients, caregivers and the curious.
Uganda is continuing to build out its medical cannabis industry with the launch of a national cooperative bringing together producers, investors, and stakeholders in the medical cannabis and...
For the first time in Ukraine, a cancer patient was able to obtain a cannabis-based medication through the national prescription system...
A new German study suggests that medical cannabis could help women with endometriosis relieve their chronic pelvic pain and reduce their dependence on...
CBD may help reduce muscle soreness and promote muscle recovery after intense exercise. This is what a new scientific review suggests,...
Chilean cannabis clubs have proliferated over the past decade, but their expansion has followed a particularly uneven geographic pattern. A new study...
New York State has authorized a clinical trial of a THC-based medication for the treatment of chronic pain. The study will evaluate...
The U.S. Drug Enforcement Administration (DEA) continues to integrate medical cannabis into the federal regulatory framework. Since October 5, 2026, producers, distributors, and laboratories...
Florida is approaching a symbolic milestone: one million patients enrolled in its medical cannabis program. According to the latest data released by the Office...
Scientists at the University of São Paulo have developed experimental eye drops containing cannabidiol (CBD) designed to relieve inflammation and pain...
A new study conducted by Minnesota’s Office of Cannabis Management (OCM) provides one of the most comprehensive datasets to date on the use...
Jamaica is continuing its efforts to integrate small-scale growers into its legal cannabis market. Six years after launching initiatives aimed at...
Bedrocan’s difficulties in the Netherlands could have repercussions beyond the country’s borders. In Denmark, Stenocare is now warning that a disruption in the supply of cannabis products...
A new study conducted on mice suggests that exposure to THC during adolescence may temporarily disrupt the energy metabolism of brain cells, with effects...
The Parliament of the State of New South Wales, in Australia, has passed a law aimed at preventing patients who are legally prescribed...
Yongji Health, a Chinese company that is already a shareholder in Tasmanian Botanics, has completed the acquisition of the shares still held by the Australian producer’s original investors. A transaction worth...
A CBDA-rich cannabis extract has shown promising results in a placebo-controlled clinical trial involving children and adolescents...
Canada, the Netherlands, Italy, Germany, Australia, the United Kingdom… While France is still waiting for general access to medical cannabis to become a reality, many countries have already allowed...
South Korea is preparing to change its approach to medical cannabis. Faced with a rise in the number of patients and the cost of imported treatments,...
While the legalization of cannabis has gradually expanded across the United States, use among teenagers is not following the trajectory feared by some opponents of...
The Danish medical cannabis program saw a sharp increase in usage in 2025, with more than 22,000 prescriptions issued to nearly...